Courier Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Courier Capital's GILD Position: Q2 2026 in Review
Courier Capital increased its Gilead Sciences (GILD) stake by 0.23% in Q2 2026, buying an estimated $527 and bringing the position to 1,773 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #376.
Courier Capital first reported a position in GILD in Q3 2014 and has held it in 18 quarters since. The position peaked at $4.23M in Q3 2017. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Courier Capital held 1,773 shares of Gilead Sciences worth $224K as of Q2 2026.
- Courier Capital bought 4 Gilead Sciences shares in Q2 2026, an estimated $527.
- Gilead Sciences made up 0.01% of Courier Capital's portfolio in Q2 2026, its #376 holding.
- Courier Capital first reported a position in Gilead Sciences in Q3 2014 and has held it in 18 quarters since.
- Courier Capital's Gilead Sciences position peaked at $4.23M in Q3 2017.
- 1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.